Migdal Insurance & Financial Holdings’s Moleculin Biotech MBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-95	Closed	-$2K	–	656
2021 Q4	$2K	Sell	95 -57	-38%	-$1.2K	﹤0.01%	667
2021 Q3	$7K	Buy	+152	New	+$7K	﹤0.01%	621